Rigel Pharmaceuticals

RIGLNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$750.370 M

$40.17 +2.42%

Close of 7 Aug 2026

Revenue

$294.3M

#2145 by revenue

Earnings

$367.0M

#755 by earnings

Shares outstanding

18,679,864

Latest filing cover page

P/E ratio

2.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#180CryoportCYRX$762.1M
#181CytomX TherapeuticsCTMX$753.3M
#182Rigel PharmaceuticalsRIGL$750.4M
#183BridgeBio Oncology TherapeuticsBBOT$747.4M
#184Gyre TherapeuticsGYRE$743.6M

Where these numbers come from

Share counts and financials for Rigel Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.